Live from the Markets: big warning from Airbus, Merck KGaA fails in phase III, Eurofins defends itself

Live from the Markets: big warning from Airbus, Merck KGaA fails in phase III, Eurofins defends itself
Live from the Markets: big warning from Airbus, Merck KGaA fails in phase III, Eurofins defends itself

Every morning, the - team identifies and summarizes the significant information concerning listed companies around the world, to have the main news at the start of the trading day. The content includes one part on France and the other on the main international markets, in particular American companies and those from major European markets (UK, Germany, Switzerland, Italy, Spain) and Asia-Pacific.

In France

Important (and less important) announcements

  • Airbus reduces its delivery targets and delays production, in particular because of Spirit Aero. The 2024 Ebit objective increases from “€6.5 to €7 billion” to €5.5 billion.
  • Exxon Mobil and Air Liquide agree to support low-carbon hydrogen production.
  • Société Générale repurchased 11.7 million of its own shares with a view to canceling them.
  • Eurofins has denied allegations of financial wrongdoing made by short seller Muddy Waters, adding that it will provide a detailed list of facts raised in the report “in due course”. The answer here.
  • Air France-KLM is keeping an eye on TAP.
  • GTT receives an order to design tanks for 10 LNG carriers.
  • JCDecaux returns to Sydney Airport.
  • Wendel would recover €14.6 million from the sale of Preligens to Safran.
  • Trigano revenues up 10.8% in fiscal Q3.
  • Eramet and BASF cancel their $2.6 billion investment plan in a cobalt and nickel refining complex in Indonesia.
  • The initiators of the takeover bid for Believe will hold 94.99% of the capital at the end of the offer.
  • Riber wins an order for an MBE 49 GaN production system in Asia.
  • Largo issues €4 million in convertible bonds for the benefit of Eiffel Investment Group funds, with exercise price of EUR 2.65, with potential dilution of 30%.
  • Carmat changes president: Pierre Bastid (administrator and large shareholder) replaces Alexandre Conroy.
  • Hôtels de Paris are postponing the publication of their annual report due to technical and regulatory difficulties beyond the company’s control.
  • Maat Pharma appoints a new medical director.
  • Theraclion is completing the treatments of the pivotal study with Sonovein, the results of which will be known in the summer of 2025.
  • The main publications of the day: Prismaflex…

In the big world

Important (and less important) announcements

D’Europe

  • UBS will sell the majority of its stake in the Chinese subsidiary of Credit Suisse to a fund backed by Beijing.
  • The Novo Nordisk CEO’s hearing before the US Senate is scheduled for September 24. Novo Nordisk which will spend $4.1 billion to strengthen its production in the United States. Finally, Teva is launching a generic version of the diabetes drug Victoza de Novo. Novo Nordisk finally announces that Semaglutide is approved for long-term weight management in China.
  • Merck KGaA ends phase III trials of its anticancer drug Xevinapant.
  • AstraZeneca announces the failure of the late-phase trial of Imfinzi for the treatment of a type of lung cancer.
  • Leonardo’s Italian factory will close for four months due to problems with Boeing’s B787.
  • The main publications of the day : Hornbach Baumarkt…

From the Americas

  • The Fed is easing its reform of bank capital.
  • Boeing’s offer for Spirit Aero values ​​the supplier at $35 per share, according to Bloomberg. The WSJ announces that the offer will be in securities.
  • DuPont’s water unit is attracting interest from potential buyers, according to Bloomberg.
  • AT&T wants big tech companies to contribute to the telecom and broadband grant fund.
  • Electric vehicle manufacturer Rivian is simplifying its production, reducing costs and aiming for its first profit.
  • Paramount Global is raising prices for its streaming offerings.
  • Rite Aid wins against MedImpact in dispute over sale of Elixir for $200 million.
  • Apple and Meta are no longer discussing an AI partnership, according to Bloomberg.
  • Hess CEO joins Goldman Sachs board as independent director.
  • The main publications of the day : Fedex, Alimentation Couche-Tard, Carnival…

From the rest of the globe

  • The United States is opening an investigation into China Telecom, China Unicom and China Mobile over the risk the operators pose to the American internet, according to Reuters.
  • The Chinese company BYD is launching a third electric vehicle model in Japan.
  • South Korea’s SK Group, which notably owns SK Hynix, is considering asset sales and mergers as part of a major restructuring.
  • Malaysia abandons privatization of Malaysia Airports Holdings.
  • The main publications of the day : Oracle Corporation Japan…

The rest of the global publications calendar here.

Lectures

-

-

PREV country houses are no longer popular
NEXT local clothing brands “made in France” are suffering